Cor Vasa 2008, 50(2):K41-K47

Doporučení pro diagnostiku a léčbu dyslipidemií u dětí a dospívajících, vypracované výborem České společnosti pro aterosklerózu

Published: February 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Doporučení pro diagnostiku a léčbu dyslipidemií u dětí a dospívajících, vypracované výborem České společnosti pro aterosklerózu. Cor Vasa. 2008;50(2):K41-47.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. American Academy of Pediatrics. National cholesterol education program: report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992;89:525-84. Go to original source... Go to PubMed...
    2. American Academy of Pediatrics - Committee on Nutrition. Statement on Cholesterol. Pediatrics 1992;90:469-73. Go to original source... Go to PubMed...
    3. Gidding SS, Dennison BA, Birch LL, et al. Dietary recommendations for children and adolescents: a guide for practicioners: consensus statement from the American Heart Association. Circulation 2005;112:2061-75. Go to original source... Go to PubMed...
    4. Groner JA, Joshi M, Beuer JA. Pediatric precursors of adult cardiovascular disease: noninvasive assessment of early vascular changes in children and adolescents. Pediatrics 2006;118:1689-93. Go to original source... Go to PubMed...
    5. Kavey RW, Stephen RD, Lauer MR, et al. American Heart Association Guidelines for Primary Prevention of Atherosclerotic Cardiovascular Disease Beginning in Childhood. Circulation 2003;107:1562-6. Go to original source...
    6. Steinberger J, Daniels SR. Obesity, Insulin Resistance, Diabetes and Cardiovascular Risk in Children. An American Heart Association Scientific Statement From the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation 2003;107:1448-53. Go to original source...
    7. McCrindle BW, Urbina EM, Dennison BA, et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation 2007;115:1948-67. Go to original source... Go to PubMed...
    8. Urbanová Z, Šamánek M, Češka R, et al. Doporučení pro diagnostiku a léčbu hyperlipoproteinemií v dětství a dospívání vypracované výborem České společnosti pro aterosklerózu. Čas Lék čes 1998;137:89-92.
    9. US Preventive Services Task Force. Screening for lipid disorders in children: US Preventive Services Task Force Recommendation Statement. Pediatrics 2007; 120:215-9. Go to original source... Go to PubMed...
    10. Vaverková H, Soška V, Rosolová H, a spol. Doporučení pro dignostiku a léčbu dyslipidemií v dospělosti, vypracované výborem České společnosti pro aterosklerózu. Cor Vasa 2007;49:K 73-K 86.

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes